Seattle Genetics CEO Clay Siegall's 2018 pay jumps 110% to $18M
Seattle Genetics reports 2018 executive compensation
By ExecPay News
Published: April 4, 2019
Seattle Genetics reported fiscal year 2018 executive compensation information on April 4, 2019.
In 2018, six executives at Seattle Genetics received on average a compensation package of $7.3M, a 102% increase compared to previous year.
Average pay of disclosed executives at Seattle Genetics
Clay B. Siegall, Chief Executive Officer, received $18M in total, which increased by 110% compared to 2017. 45% of Siegall's compensation, or $8.2M, was in stock awards. Siegall also received $2K in bonus, $1.4M in non-equity incentive plan, $7.5M in option awards, $919K in salary, as well as $19K in other compensation.
For fiscal year 2018, the median employee pay was $198,658 at Seattle Genetics. Therefore, the ratio of Clay B. Siegall's pay to the median employee pay was 91 to one.
Roger D. Dansey, Chief Medical Officer, received a compensation package of $9.9M. 69% of the compensation package, or $6.8M, was in stock awards.
Todd E. Simpson, Chief Financial Officer, earned $4.4M in 2018, a 45% increase compared to previous year.
Vaughn B. Himes, Chief Technical Officer, received $4M in 2018, which increases by 43% compared to 2017.
Darren Cline, Former Executive Vice President, Commercial, earned $3.9M in 2018, a 61% increase compared to previous year.
Jean I. Liu, General Counsel, received $3.8M in 2018, which increases by 57% compared to 2017.
Related executives
Clay Siegall
Seattle Genetics
Chief Executive Officer
Todd Simpson
Seattle Genetics
Chief Financial Officer
Roger Dansey
Seattle Genetics
Chief Medical Officer
Vaughn Himes
Seattle Genetics
Chief Technical Officer
Darren Cline
Seattle Genetics
Former Executive Vice President, Commercial
Jean Liu
Seattle Genetics
Chief Legal Officer
You may also like
Source: SEC filing on April 4, 2019.